71 related articles for article (PubMed ID: 12773323)
21. Surfactant protein A decreases nitric oxide production by macrophages in a tumor necrosis factor-alpha-dependent mechanism.
Hussain S; Wright JR; Martin WJ
Am J Respir Cell Mol Biol; 2003 Apr; 28(4):520-7. PubMed ID: 12654642
[TBL] [Abstract][Full Text] [Related]
22. Production of nitric oxide by rat type II pneumocytes: increased expression of inducible nitric oxide synthase following inhalation of a pulmonary irritant.
Punjabi CJ; Laskin JD; Pendino KJ; Goller NL; Durham SK; Laskin DL
Am J Respir Cell Mol Biol; 1994 Aug; 11(2):165-72. PubMed ID: 7519435
[TBL] [Abstract][Full Text] [Related]
23. Response of alveolar macrophages from inducible nitric oxide synthase knockout or wild-type mice to an in vitro lipopolysaccharide or silica exposure.
Zeidler PC; Roberts JR; Castranova V; Chen F; Butterworth L; Andrew ME; Robinson VA; Porter DW
J Toxicol Environ Health A; 2003 Jun; 66(11):995-1013. PubMed ID: 12775513
[TBL] [Abstract][Full Text] [Related]
24. Human surfactant protein a suppresses T cell-dependent inflammation and attenuates the manifestations of idiopathic pneumonia syndrome in mice.
Yang S; Milla C; Panoskaltsis-Mortari A; Ingbar DH; Blazar BR; Haddad IY
Am J Respir Cell Mol Biol; 2001 May; 24(5):527-36. PubMed ID: 11350821
[TBL] [Abstract][Full Text] [Related]
25. Regulation of nitric oxide release by macrophages after intratracheal lipopolysaccharide.
Shellito JE; Kolls JK; Summer WR
Am J Respir Cell Mol Biol; 1995 Jul; 13(1):45-53. PubMed ID: 7541222
[TBL] [Abstract][Full Text] [Related]
26. Role of mitogen-activated protein kinase activation in the production of inflammatory mediators: differences between primary rat alveolar macrophages and macrophage cell lines.
Rao KM; Meighan T; Bowman L
J Toxicol Environ Health A; 2002 May; 65(10):757-68. PubMed ID: 12028827
[TBL] [Abstract][Full Text] [Related]
27. Fructose-1,6-diphosphate attenuates acute lung injury induced by lipopolysaccharide in mice.
Yin H; Jin XB; Gong Q; Yang H; Hu LY; Gong FL; Zhu JY
Int Immunopharmacol; 2008 Dec; 8(13-14):1842-7. PubMed ID: 18824250
[TBL] [Abstract][Full Text] [Related]
28. [Effect of surfactant on mouse alveolar macrophage cytotoxicity].
Takahashi N; Masutani M; Horie T
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Jul; 31(7):859-66. PubMed ID: 8366624
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory effect of naringin on lipopolysaccharide (LPS)-induced endotoxin shock in mice and nitric oxide production in RAW 264.7 macrophages.
Kanno S; Shouji A; Tomizawa A; Hiura T; Osanai Y; Ujibe M; Obara Y; Nakahata N; Ishikawa M
Life Sci; 2006 Jan; 78(7):673-81. PubMed ID: 16137700
[TBL] [Abstract][Full Text] [Related]
30. Flavopiridol inhibits lipopolysaccharide-induced TNF-α production through inactivation of nuclear factor-κB and mitogen-activated protein kinases in the MyD88-dependent pathway.
Haque A; Koide N; Iftakhar-E-Khuda I; Noman AS; Odkhuu E; Badamtseren B; Naiki Y; Komatsu T; Yoshida T; Yokochi T
Microbiol Immunol; 2011 Mar; 55(3):160-7. PubMed ID: 21204955
[TBL] [Abstract][Full Text] [Related]
31. Deficiency in inducible nitric oxide synthase protects mice from ozone-induced lung inflammation and tissue injury.
Fakhrzadeh L; Laskin JD; Laskin DL
Am J Respir Cell Mol Biol; 2002 Apr; 26(4):413-9. PubMed ID: 11919077
[TBL] [Abstract][Full Text] [Related]
32. Surfactant-associated protein A inhibits LPS-induced cytokine and nitric oxide production in vivo.
Borron P; McIntosh JC; Korfhagen TR; Whitsett JA; Taylor J; Wright JR
Am J Physiol Lung Cell Mol Physiol; 2000 Apr; 278(4):L840-7. PubMed ID: 10749762
[TBL] [Abstract][Full Text] [Related]
33. Extract of the seed coat of Tamarindus indica inhibits nitric oxide production by murine macrophages in vitro and in vivo.
Komutarin T; Azadi S; Butterworth L; Keil D; Chitsomboon B; Suttajit M; Meade BJ
Food Chem Toxicol; 2004 Apr; 42(4):649-58. PubMed ID: 15019190
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of surfactant protein SP-A, SP-B, and SP-C mRNA in rat lungs with lipopolysaccharide-induced injury.
Sugahara K; Iyama K; Sano K; Kuroki Y; Akino T; Matsumoto M
Lab Invest; 1996 Jan; 74(1):209-20. PubMed ID: 8569184
[TBL] [Abstract][Full Text] [Related]
35. Anionic pulmonary surfactant phospholipids inhibit inflammatory responses from alveolar macrophages and U937 cells by binding the lipopolysaccharide-interacting proteins CD14 and MD-2.
Kuronuma K; Mitsuzawa H; Takeda K; Nishitani C; Chan ED; Kuroki Y; Nakamura M; Voelker DR
J Biol Chem; 2009 Sep; 284(38):25488-500. PubMed ID: 19584052
[TBL] [Abstract][Full Text] [Related]
36. Interaction of bacterial lipopolysaccharide with mouse surfactant protein C inserted into lipid vesicles.
Augusto L; Le Blay K; Auger G; Blanot D; Chaby R
Am J Physiol Lung Cell Mol Physiol; 2001 Oct; 281(4):L776-85. PubMed ID: 11557581
[TBL] [Abstract][Full Text] [Related]
37. Interaction of pulmonary surfactant protein C with CD14 and lipopolysaccharide.
Augusto LA; Synguelakis M; Johansson J; Pedron T; Girard R; Chaby R
Infect Immun; 2003 Jan; 71(1):61-7. PubMed ID: 12496149
[TBL] [Abstract][Full Text] [Related]
38. The role of nitric oxide in lung innate immunity: modulation by surfactant protein-A.
O'Reilly P; Hickman-Davis JM; McArdle P; Young KR; Matalon S
Mol Cell Biochem; 2002; 234-235(1-2):39-48. PubMed ID: 12162458
[TBL] [Abstract][Full Text] [Related]
39. Induction of TNF-alpha release from human buffy coat cells by Pseudomonas aeruginosa is reduced by lung surfactant protein A.
Hickling TP; Sim RB; Malhotra R
FEBS Lett; 1998 Oct; 437(1-2):65-9. PubMed ID: 9804173
[TBL] [Abstract][Full Text] [Related]
40. Nitric oxide and lung surfactant.
Hallman M; Bry K
Semin Perinatol; 1996 Jun; 20(3):173-85. PubMed ID: 8870120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
